Thursday, 25 April 2024
Tianjin Zhong Xin Pharm Group
18:45 | 15/8/11
CapitalVue
August 15 -- Tianjin Lisheng Pharmaceutical (002393), a maker of cardiovascular and antihypertensive medicines, plans to purchase 49 percent and 51 percent stakes in Tianjin Central Pharma from ...
more»
21:26 | 29/4/11
Reuters Key Development
Tianjin Zhong Xin Pharmaceutical Group Does Not Recommend Dividend
more»
23:28 | 30/3/11
Business Times
By MINDY TAN Tianjin Zhong Xin Pharmaceutical Group posted a net profit of RMB293.29 million (US$44.62 million) for the financial year ended 31 December 2010, up 9 per cent from 2009. Revenue for ...
more»
22:19 | 30/3/11
Reuters Key Development
Tianjin Zhong Xin Pharmaceutical Group Announces Final Dividend
more»
Code | Last | Change |
COMP | 10,321 | 328 | | 3.08% |
DJI | 29,635 | 404 | | 1.34% |
SP500 | 3,583 | 87 | | 2.37% |
DAX | 12,438 | 82 | | 0.67% |
FTSE | 7,488 | 5 | | 0.07% |
NI225 | 22,420 | 408 | | 1.86% |
TWI | 67.27 | 0.00 | | 0.00% |